MiR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3

Molecular and Cellular Biochemistry

Volumn 388, Issue 1-2, 2014, Pages 219-231

  Li, Yunyun ^a   Zhang, Zhongzu ^a   Liu, Xiuxia ^a,b,c   Huang, Tingting ^d   He, Wenfeng ^b,c   Shen, Yang ^b,c   Liu, Xin ^b,c   Hong, Kui ^b,c   Cao, Qing ^a,b,c  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Provincial Key Laboratory of Molecular Medicine   (China)

^c Cardiovascular Systemetic Key Laboratory of Jiangxi Province   (China)

^d Jiangxi Maternal and Child Health Hospital   (China)

Author keywords

Cyclin D2; Endometrial carcinoma; Matrix metalloproteinase 2; MicroRNA; miR 124; STAT3 transcription factor

Indexed keywords

3' UNTRANSLATED REGIONS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D2; ENDOMETRIAL NEOPLASMS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 2; MICRORNAS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84893873513     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1913-2     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57(1):43-66
2. Barrena Medel NI, Bansal S, Miller DS, Wright JD, Herzog TJ (2009) Pharmacotherapy of endometrial cancer. Expert Opin Pharmacother 10(12):1939-1951. doi: 10.1517/14656560903061291
3. Banno K, Yanokura M, Kisu I, Yamagami W, Susumu N, Aoki D (2013) MicroRNAs in endometrial cancer. Int J Clin Oncol 18(2):186-192. doi: 10.1007/s10147-013-0526-9
4. Devor EJ, Hovey AM, Goodheart MJ, Ramachandran S, Leslie KK (2011) microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs. Oncol Rep 26(4):995-1002. doi: 10.3892/or2011.1372
5. Shang C, Lu YM, Meng LR (2012) MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit 18(4):BR149-BR155
6. Lee JW, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS (2011) The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol 120(1):56-62. doi: 10.1016/j.ygyno.2010. 09.022
7. Yanokura M, Banno K, Kobayashi Y, Kisu I, Ueki A, Ono A, Masuda K, Nomura H, Hirasawa A, Susumu N, Aoki D (2010) MicroRNA and endometrial cancer: roles of small RNAs in human tumors and clinical applications (Review). Oncol Lett 1(6):935-940. doi: 10.3892/ol.2010.173
8. Kala R, Peek GW, Hardy TM, Tollefsbol TO (2013) MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinform 3(1):6. doi: 10.1186/2043-9113-3-6
9. Philippe L, Alsaleh G, Bahram S, Pfeffer S, Georgel P (2013) The miR-17 approximately 92 cluster: a key player in the control of inflammation during Rheumatoid Arthritis. Front Immunol 4:70. doi: 10.3389/fimmu.2013.00070
10. Wang MJ, Li Y, Wang R, Wang C, Yu YY, Yang L, Zhang Y, Zhou B, Zhou ZG, Sun XF (2013) Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer. Int J Colorectal Dis 28(2):183-189. doi: 10.1007/s00384-012-1550-3
11. Xia Q, Hu J, Meng YS (2012) Abnormal expression of microRNA-124 in patients with leukemia or myelodysplastic syndrome and its significance. J Exp Hematol 20(2):358-361
12. Shi XB, Xue L, Ma AH, Tepper CG, Gandour-Edwards R, Kung HJ, Devere White RW (2012) Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene. doi: 10.1038/onc.2012.425
13. Snellenberg S, De Strooper LM, Hesselink AT, Meijer CJ, Snijders PJ, Heideman DA, Steenbergen RD (2012) Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. BMC Cancer 12:551. doi: 10.1186/1471-2407-12-551
14. Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, le Sage C, Agami R, Snijders PJ, Steenbergen RD (2010) Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 9:167. doi: 10.1186/1476-4598-9-167
15. Cai B, Li J, Wang J, Luo X et al (2012) MicroRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling. Stem Cells 30(8):1746-1755. doi: 10.1002/stem.1154
16. Matsui T, Kinoshita T, Hirano T, Yokota T, Miyajima A (2002) STAT3 down-regulates the expression of cyclin D during liver development. J Biol Chem 277(39):36167-36173. doi: 10.1074/jbc.M203184200
17. Ataie-Kachoie P, Morris DL, Pourgholami MH (2013) Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies. PLoS ONE 8(4):e60817. doi: 10.1371/journal.pone.0060817
18. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos D (2011) An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147(6):1233-1247. doi: 10.1016/j.cell.2011.10.043
19. Zhong Z, Wen Z, Darnell JE Jr (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264(5155):95-98 (Pubitemid 24144493)
20. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297 (Pubitemid 38167318)
21. Schwabe RF, Wang TC (2011) Targeting liver cancer: first steps toward a miracle? Cancer Cell 20(6):698-699. doi: 10.1016/j.ccr.2011.11.021
22. Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E (2011) Breast cancer and microRNAs: therapeutic impact. Breast 20(Suppl 3):S63-S70. doi: 10.1016/s0960-9776(11)70297-1
23. Lv XB, Jiao Y, Qing Y, Hu H, Cui X, Lin T, Song E, Yu F (2011) miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin J Cancer 30(12):821-830. doi: 10.5732/cjc.011.10289
24. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264(5164):1415-1421 (Pubitemid 24217131)
25. Bollrath J, Greten FR (2009) IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10(12):1314-1319. doi: 10.1038/embor.2009.243
26. Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, Wallace JA, Cheng G, Hall BM, Lin J (2007) Stat3 activation in human endometrial and cervical cancers. Br J Cancer 96(4):591-599. doi: 10.1038/sj.bjc.6603597
27. Tang JZ, Kong XJ, Banerjee A, Muniraj N, Pandey V, Steiner M, Perry JK, Zhu T, Liu DX, Lobie PE (2010) STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone. Endocrinology 151(9):4133-4145. doi: 10.1210/en.2010-0273
28. Sharma D, Saxena NK, Vertino PM, Anania FA (2006) Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer 13(2):629-640. doi: 10.1677/erc.1.01169 (Pubitemid 43886682)
29. Lang Q, Ling C (2012) miR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochem Biophys Res Commun 426(2):247-252. doi: 10.1016/j.bbrc.2012.08.075
30. Silber J, Hashizume R, Felix T, Hariono S, Yu M, Berger MS, Huse JT, VandenBerg SR, James CD, Hodgson JG, Gupta N (2013) Expression of miR-124 inhibits growth of medulloblastoma cells. Neuro-oncology 15(1):83-90. doi: 10.1093/neuonc/nos281
31. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR, Zhao Q (2013) miR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 34(3):713-722. doi: 10.1093/carcin/bgs383